Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.35
-$0.5832-3.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.29% | 39.70% | -84.06% | -83.62% | 10.27% |
| Total Depreciation and Amortization | 25.21% | 21.23% | 22.61% | 25.98% | 6.17% |
| Total Amortization of Deferred Charges | -- | -- | -0.80% | 1.91% | -- |
| Total Other Non-Cash Items | 70.54% | 65.11% | 797.36% | 821.97% | 102.62% |
| Change in Net Operating Assets | 244.16% | 239.57% | 23.06% | 26.43% | 92.05% |
| Cash from Operations | 50.46% | 45.67% | 12.44% | 15.52% | 8,017.37% |
| Capital Expenditure | 84.84% | 85.32% | 32.11% | 30.24% | -132.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.04% | -30.74% | 3.62% | 0.98% | -106.11% |
| Cash from Investing | 79.79% | 80.43% | 28.58% | 26.62% | -461.06% |
| Total Debt Issued | -80.95% | -80.95% | -17.64% | -17.64% | 663.64% |
| Total Debt Repaid | -43.62% | -43.62% | -65.16% | -65.16% | -847.76% |
| Issuance of Common Stock | 25.00% | 25.00% | 28.57% | 28.57% | -25.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.24% | -4.80% | 20.95% | 18.79% | 38.02% |
| Other Financing Activities | -7.07% | -7.07% | -562.92% | -562.92% | 37.09% |
| Cash from Financing | -310.08% | -303.40% | -111.40% | -117.20% | 160.51% |
| Foreign Exchange rate Adjustments | -744.26% | -723.90% | 132.43% | 133.32% | -88.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 168.92% | 166.73% | -71.68% | -70.91% | -116.16% |
